ABSTRACT This 42-day study evaluated the effects of dietary supplementation with β-1,3-glucan (Aleta TM ) on the vaccination response to Newcastle disease virus (NDV), avian infectious bronchitis virus (IBV), and infectious bursal disease (IBD) in a non-challenged environment. This trial included 600 chicks (all vaccinated with IBD at the hatchery) which were assigned to 1 of 3 treatments: vaccination (NDV, IBV), no vaccination, or vaccination combined with feed supplemented with Aleta (100 g/MT of feed). The vaccination with Aleta treatment group showed a trend for improved FCR that was not statistically significant. Control birds that were not vaccinated for IBV had significantly lower IBV titers on day 21 compared to birds that were vaccinated (both with and without Aleta). Surprisingly, there was significant separation among treatment groups for NDV titer levels, especially on day 21, where birds vaccinated and supplemented with Aleta had significantly higher titer levels compared to vaccination alone or no vaccination at all. Critically, only 14% of the birds receiving the vaccine plus Aleta had titer levels below the critical titer threshold for immunity compared to 28% of the birds receiving the vaccine alone and 40% of the unvaccinated birds. This suggests that Aleta supplementation may help to improve the vaccination response by birds, especially for NDV.
INTRODUCTION
Until recently, the prophylactic supplementation of animal feed with antibiotics was common. This practice led to reduced incidence of some diseases, increased growth rates, and improved feed efficiency in poultry and other livestock. There is now, however, increasing evidence that such long-term, and nonspecific, exposure to antibiotics leads to bacterial resistance with significant impacts on the future efficacy of these critical drugs (Aarestrup, 2005) . Consequently, several countries have restricted or banned the prophylactic use of antibiotics in animal feed. This gives a new urgency to the search for alternative strategies to maintain animal performance and protect animals from disease.
One promising strategy is the use of immune modulators such as beta-1,3-glucan to bolster an animal's innate immunity (Chan et al., 2009; Barsanti et al., 2011) . When animals are exposed to beta glucan, their immune system detects the molecule as a pathogenassociated molecular pattern, which triggers a cascade of immune system responses. This response has evolved over time since beta-1,3-glucan is found in the cells of potentially pathogenic organisms such as fungi, yeast, and bacteria.
In poultry, supplementing feeds with beta-1,3-glucan has shown to increase immune cell activation (Guo et al., 2003; Chae et al., 2006; Lowry et al., 2005) and immune cell recruitment to the gut (Levine et al., 2018) . Subsequently, several groups have demonstrated improved resistance to bacterial infections (Lowry et al., 2005; Huff et al., 2006; Chen et al., 2008) , improved intestinal health following coccidiosis infection (Cox et al., 2010; Levine et al., 2018) , and overall improvements in growth rates and feed conversion efficiency (Chae et al., 2006; An et al., 2008; Zhang et al.. 2008; Morales-Lopez et al., 2009; Cox et al., 2010; Moon et al., 2016; Levine et al., 2018) .
Vaccination is another key tool to help protect animals from certain types of diseases, especially viral diseases such as infectious bronchitis (IBV), infectious bursal disease (IBD), and Newcastle disease (ND). However, there are not vaccines for all major diseases and the response to certain vaccines, especially Newcastle disease virus (NDV), can be variable, which leaves some birds unprotected and can put a flock at risk of an outbreak (van Boven et al., 2008; Botus et al., 2010; Hossain et al., 2010; Ghahramani et al., 2014) . Previous studies to determine potential synergistic effects of yeast-based beta glucans and vaccines have been mixed: Cheng et al. (2004) showed no effect on ND titers, 1643 whereas An et al. (2008) showed significant increases in both ND and IBV titers in birds supplemented with beta glucan.
In this study, we examine whether supplementation with Aleta TM (a highly-concentrated beta-1,3-glucan product) can improve the immune response to NDV and IBV vaccination and improve performance metrics in a 42-day pen trial.
MATERIALS AND METHODS

Experimental Design
In this 12-pen study, 600 chicks were assigned to 3 treatment groups with 4 replicate pens, with 50 birds allocated per pen. Treatment groups were assigned to pens using randomized complete block design. Southern Poultry Research Group completed randomization and assignment of treatment groups to pens using random permutation tables (Cochran and Cox, 1992) . 
Treatment Groups
Birds
A total of 600 day-of-hatch Aviagen straight run broiler chicks were obtained from Baldwin, GA. Birds were non-sexed and received routine vaccinations (HVT-IBD [Vaxxitek R , Boehringer Ingelheim]), and breeder flock number information was recorded at the hatchery. All animal handling procedures complied with the Institutional Animal Care and Use Committee. The study began when day-of-hatch birds were placed in treatment groups on day 0 and allocated to experimental pens. Only healthy appearing birds were allocated for study use, and the final number and disposition of all birds not allocated was documented. No birds were replaced during the study. Each bird was also tagged and used as the unit of measure for virus titers. Pen security prevented bird migration.
All birds were monitored for general flock condition, temperature, lighting, water, feed, litter condition, unanticipated house conditions/events, and mortality; findings were documented twice daily during the regular working hours. Birds were culled only to relieve suffering. The date and removal weight were recorded for any bird culled (or found dead), gross necropsy was performed on all culled (or dead) birds, and gender and probable cause of death were recorded. All birds were disposed of by appropriate methods. All mortalities and remaining feeds (including mixer flushes) were buried in the Southern Poultry Research Group on-site disposal pit.
Housing and Environmental Control
At study initiation, 50 broiler chicks were allocated to 12 floor pens measuring 5 × 10 (1.0 ft 2 /bird stocking density) in a modified conventional poultry house (fan-cooled) with solid sides and dirt floors. Thermostatically controlled gas heaters were the primary heat source with supplemental heat lamps (one lamp per pen) providing heat when needed. Birds were raised under ambient humidity and were provided 24-h lighting. At placement each pen contained approximately 4 inches of fresh pine shavings. Litter was not replaced during the study course. Each pen contained 1 tube feeder and 1 bell drinker resulting in a 50-bird/feeder and drinker ratio. Feed and water were consumed ad libitum throughout the trial.
Diet
Rations were fed as follows: starter diet day 0 to 21, grower diet day 21 to 35, and finisher diet day 35to 42. Diets were fed as crumbles (starter diet) or pellets (grower and finisher diets). On day 21, 35, and 42, all previous feed was removed from each pen, individually weighed, discarded, and replaced (day 21 and 35) or discarded (day 42). Feed formulations for this study consisted of unmedicated commercial-type broiler starter and grower diets compounded with commonly used United States feedstuffs representative of local formulations, and calculated analyses met or exceeded NRC standards.
Experimental treatment feeds were prepared from a basal starter and grower feed with quantities of all basal feed and test articles used to prepare treatment batches documented. Treatment group 3 contained the basal diet supplemented with 100 g/MT of Aleta TM (Kemin Industries, Inc., Des Moines, IA). Aleta is dried Euglena gracilis, a single-celled organism, which contains approximately 50% beta glucan by weight. To assure uniform distribution of the beta glucan, pre-pelleted treatment feeds were mixed at the Southern Poultry Research feed mill and pelleted in a California Pellet mill at 80
• C (with pellet temperature recorded). After mixing was completed, feed was distributed among pens of designated treatment groups.
Vaccination
On arrival at Southern Poultry Research Group and before placement, all chicks in treatment groups 2 and 3 were eye dropped with one dose of ND vaccine (C2) and one dose of IBV vaccine (GA98). A boost was repeated by eye drop at 21 d of age to all birds. No concomitant drug therapy was used during the study. To prevent cross-contamination, plastic disposable boots were worn when entering pens and changed between each pen.
Performance Parameters
Bird weights by pen were recorded on day 0 and day 42. Thirty birds per treatment group were bled on day 7, 21, and 42 for the serology study. Serum was stored in a freezer until trial termination. All serum was tested for ND, IBV, and IBD by ELISA at one time with the same IDEXX kit (IDEXX, Westbrook, ME).
Statistical Analysis
Mortality, weight gain, and feed conversion metrics were analyzed by ANOVA using individual pens as replicates. Viral titers were not normally distributed after Log 2 distributions, especially for NDV and IBV titers. Therefore, titer statistical comparisons among treatment groups (using individual birds as replicates) were performed using the non-parametric KruskalWallis rank test followed by Conover post hoc pairwise comparisons which corrects for multiple comparisons (Sokal and Rohlf, 2001 ).
RESULTS AND DISCUSSION
Performance Parameters
Overall, there were no significant differences in mortality, weight gain, or feed conversion between treatment groups (Table 1 ). This could be expected due to the low number of replicate pens (4) per treatment group and the fact that the birds were not challenged with either a biological or environmental stressor to dramatically affect growth.
Birds treated with vaccine alone had numerically lower mortality (2%) compared to unvaccinated birds (6%) and vaccinated birds fed Aleta (5%) ( Table 1) . Birds treated with vaccines (with and without supplemented Aleta) showed modest but not significant increases in weight gain compared to the control group. Vaccinated birds supplemented with Aleta had numerically the best feed conversion efficiency, showing a 2.4-point improvement (i.e., 0.024 reduction in feed conversion ratio) over the control group and a 3.6-point improvement over the vaccine alone group (Table 1) .
Serological Data
Virus titers for NDV, IBD, and IBV displayed the typical time-dependent pattern of high titer levels at day 7, reflecting the high amount of maternal antibodies still in circulation. Titer levels declined precipitously by day 21 and then climbed again by day 42, reflecting the bird's natural antibody production (Table 2) .
Aleta had no impact on IBD titer levels across all time points (Table 2 ). According to facility personnel, the IBD maternal antibody (mAb) titers at Fieldale tend to be very high and this is reflected in the high day 7 titers across all treatment groups (>4,000 or Log2 >12). The mAb declined by day 21, and the recombinant IBD vaccine titers began to rise by day 42. Since the IBD insert is in the Herpes virus (HVT) which primarily replicates in T cells (after an initial B cell), the immunity normally develops slowly to IBD.
The mAb for IBV were still present at day 7 and began to drop by day 21 (Table 2) . Since the primary immunity to IBV is local (Harderian Gland/BALT), it is not expected that measuring circulating antibodies in serum by ELISA will result in elevated titers as commonly seen with IBD or NDV. IBV is highly contagious and despite facility personnel changing boots between pens, it appears the IBV moved into the non-vaccinated pens. Vaccinated birds, both with and without Aleta, had significantly higher titers and narrower coefficient of variation (CV) than the unvaccinated control group, as expected (Table 2 ). However, there did not appear to be a strong impact of Aleta in further enhancing the titer levels for IBV in combination with vaccination.
NDV titers were most responsive to vaccination, both with and without supplementation of Aleta. On day 21, there was significant separation among the 3 treatment groups, with the vaccinated group supplemented with Aleta demonstrating the highest titer levels followed by vaccine alone and the control group with the lowest titer levels (Table 2 and Figure 1 ). The coefficient of variation was also different between groups, with the control group having the highest variation (0.89), followed by the vaccine only group (0.72), and finally the vaccinated birds supplemented with Aleta (0.47). Ideally, CVs should be less than 0.50 to be considered an effective and homogenous vaccination.
With closer inspection of the distribution of vaccine titers among treatment groups, it is apparent that the distribution is far from normal, even with Log 2 transformation (Figure 2 ). In fact, some proportion of the birds had non-detectable titer levels, far below the assumed Log 2 NDV titer of >3 in order to have protection against ND (van Boven et al., 2008; Ghahramani et al., 2014) . During the critical time period when maternal antibodies are declining and the intrinsically produced antibodies are still ramping up, many of the birds have titer levels dip below this critical threshold. In the unvaccinated group, 40% of the birds fell below this threshold and with vaccination alone, about 28% of birds were still susceptible. By stark contrast, the vaccination plus Aleta group had only 14% of the birds fall below this critical titer threshold (Figure 3) , which is biologically significant since previous studies indicate that herd immunity for NDV occurs when 85% or more of the population is above the critical titer threshold (van Boven et al., 2008) .
The effect of vaccination on NDV titer levels continued to be apparent on day 42, with both vaccinated groups having significantly higher titer levels and narrower CVs compared to the unvaccinated control, but there was no longer any separation between the vaccine alone and vaccine with Aleta groups (Table 2, Figure 2) . By day 42, nearly all birds had titers above the critical threshold and therefore differences among groups were unlikely to have an impact on disease prevention by that time period.
In this study, NDV titers were the most variable among all the virus antibodies tested. Specifically, the unvaccinated control group was characterized by a high coefficient of variation and, importantly, a large proportion of birds with low to no observable NDV titers on day 21, meaning they could be susceptible to ND leading to a potential outbreak in the population. Vaccination alone did significantly increase titers levels and decreased CV, but still a surprisingly high 28% of the population was below the critical titer levels to confer immunity. It was only with the vaccine plus Aleta supplementation that 86% of the population reached the critical titer threshold, which is above the theoretical 85% threshold for herd immunity from ND. Prior research has shown that beta glucans can increase innate immune activity while also prime critical immune cells involved in adaptive immunity including both Band T cells (Guo et al., 2003) ; this may be a potential mechanism for improving vaccine responsiveness seen among birds supplemented with Aleta in combination with normal vaccination protocols.
